Institutional members access full text with Ovid®

Share this article on:

Celecoxib and Cardiovascular Risk

Kayyali, Andrea MSN, RN

AJN The American Journal of Nursing: March 2009 - Volume 109 - Issue 3 - p 29
doi: 10.1097/01.NAJ.0000346923.59875.c9
Drug Watch
  • High doses of celecoxib produced the greatest cardiovascular risk.
  • Adverse events occurred most often in patients with the greatest baseline risk.
© 2009 Lippincott Williams & Wilkins, Inc.